Kenneth M. Shermock - Concepedia

Author

Kenneth M. Shermock

Also Known As

K Shermock, K. Shermock, K.M. SHERMOCK, K.M. Shermock, Kenneth M Shermock, Kenneth M. Shermock, Kenneth Shermock, Sanket Shah

137

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Hospital Johns Hopkins Medicine Cleveland Clinic Cleveland Foundation

About

Kenneth M. Shermock is an author at Johns Hopkins University specializing in medicine, public health, and patient safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	19	1.1K
2	Health Sciences	2	2	125
3	Business	1	1	10
4	Engineering	1	1	13
5	Nursing	1	1	135

Kenneth M. Shermock

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: A prospective, randomized trial John J. Vargo, Gregory Zuccaro, John A. Dumot, Gastroenterology Advanced Upper EndoscopyPatient SafetyGastroenterologyEus-guided GastroenterostomySurgery	2002	341
Cost effectiveness of interferon α2b combined with ribavirin for the treatment of chronic hepatitis C Zobair M. Younossi, Mendel E. Singer, John G. McHutchison, Hepatology	1999	161
Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model Todd Nesbit, Kenneth M. Shermock, Mary Beth Bobek, American Journal of Health-System Pharmacy NursingFamily MedicinePharmacoeconomic AnalysisPrimary CareHealth Economics	2001	135
Change in Reported Adherence to Nonpharmaceutical Interventions During the COVID-19 Pandemic, April-November 2020 Matthew A. Crane, Kenneth M. Shermock, Saad B. Omer, JAMA Population Health SciencesRegional TrendsCovid-19 EpidemiologySocial Determinants Of HealthCovid-19	2021	133
Impact of a venous thromboembolism prophylaxis “smart order set”: Improved compliance, fewer events Amer M. Zeidan, Michael B. Streiff, Brandyn Lau, American Journal of Hematology Patient SelectionThrombosisVenous ThrombosisPreventive MedicineAdverse Event	2013	105
Activated Partial Thromboplastin Time and Anti-Xa Measurements in Heparin Monitoring Clifford M. Takemoto, Michael B. Streiff, Kenneth M. Shermock, American Journal of Clinical Pathology ImmunologyPathologyPharmacotherapyBiomedical EngineeringThrombosis	2013	90
Cost-Effectiveness Analysis of Augmentation Therapy for Severe α <sub>1</sub> -Antitrypsin Deficiency Thomas R. Gildea, Kenneth M. Shermock, Mendel E. Singer, American Journal of Respiratory and Critical Care Medicine	2003	73
Comparative Study of the Development of Diabetes Mellitus in Patients Taking Risperidone and Olanzapine Matthew A. Fuller, Kenneth M. Shermock, Michelle Secic, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2003	73
The Use of Lacosamide in Refractory Status Epilepticus Haley Goodwin, Holly E. Hinson, Kenneth M. Shermock, Neurocritical Care NeurophysiologyMedicineNeuropharmacologyClinical PharmacologyPharmacotherapy	2011	61
Patient Preferences for Receiving Education on Venous Thromboembolism Prevention – A Survey of Stakeholder Organizations Victor O. Popoola, Brandyn Lau, Hasan M Shihab, PLoS ONE	2016	60

Page 1